|
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- Gelion PLC - London-based battery energy storage systems firm - Plans to raise up to £10.0 million via placing and subscription with new and existing institutional investors at 20.0 pence per share, and a further £500,000 by a retail offer at the same price. Proceeds will be used to achieve commercial pouch cell prototypes with its tier one partner pursuant to the collaboration agreement also announced Thursday; successfully complete the prototype project with QinetiQ; progress towards product market fit with a tier one battery manufacturer; develop an additional sales integration business unit; and provide working capital. As referenced, Gelion also announces that the materials testing agreement signed with a tier one battery manufacturer in April has now transitioned to a multi-year collaboration agreement. This follows the successful and independent validation of Gelion’s advanced cathode active material. ‘This agreement allows us to move quickly to realise its full potential by collaborating with a partner with the market reach and experience,’ company says. Also announces further strengthening of its lithium-sulfur intellectual property portfolio, with the award of two patents and the acceptance of one application by the US Patent and Trademark Office. In addition, announces that the company’s sulfur cathode active material has been successfully integrated into coin cells using standard lithiumion battery and sodiumion battery electrolytes and anodes. ---------- HgCapital Trust PLC - London-based provider of access to the private equity investments of manager Hg - Hg, the manager of HgCapital Trust, agrees the sale of GTreasury, an operator in adaptable treasury solutions, to Ripple for $1 billion. HgT gives private and institutional investors the opportunity to participate in all Hg’s investments. The transaction values HgT’s investment in GTreasury at around £30 million, which would represent an uplift of £15 million, or 3.2 pence per share, over the carrying value of £15 million in the pro-forma net asset value of HgT at August 31. Based on the August 31 pro-forma NAV, the new pro-forma NAV of HgT is expected to be £2.5 billion, or 544.5 pence per share. ---------- Roquefort Therapeutics PLC - London-based biotechnology company, which focuses on developing medicines in the immunology and oncology sectors - Raises £300,000, with £200,000 by way of advance subscription agreements from certain strategic investors, and £100,000 by way of a loan from A2A Pharmaceuticals Inc. Proceeds will be used to fund the upfront costs of the proposed transaction with A2A Pharma and Coiled Therapeutics Inc which will result in Roquefort Therapeutics acquiring the exclusive licence rights to AO-252, a novel first-in-class, first-in-human new drug alternative targeting the TACC3 protein for the treatment of certain cancers, announced in September. ---------- Trafalgar Property Group PLC - South-East England-focused residential property developer - Announces that it has drawn down £100,000 from agreement announced with Wager Holdings in September. The drawdown has been made on the terms described in July’s announcement. Proceeds will be used primarily for working capital. Following this drawdown, £50,000 of the £150,000 Wager facility remains available to be drawn. ---------- T42 IOT Tracking Solutions PLC - provider of real-time tracking solutions for the freight market - Appoints advisers to seek potential investors interested in providing funding to participate in plans to develop new product and technology solutions. Expects the strategy to involve a structure with investors, partners and funding at a project level separate to the group, which would be non-dilutive to shareholders and without impact on present working capital. Believes this strategy has the potential to incorporate its products and technology across the global shipping container sector, although there can be no certainty that funding will be secured. ---------- Cloudified Holdings Ltd - British Virgin Islands-incorporated shell company - Continues to progress the previously identified acquisition opportunity announced in June, now targets completion in the first quarter of 2026. ---------- Buccaneer Energy PLC - Texas-focused exploration company, previously known as Nostra Terra Oil & Gas Co - Announces that construction has commenced at the location of its upcoming Allar number 1 well, the first of two planned development locations in the Fouke area of the Pine Mills Field. Allar 1 is ‘tentatively expected’ to spud in late October, following the completion of site preparation and associated civil works, which are now under way. Drilling operations are anticipated to take up to two weeks to complete and evaluate. ---------- Solvonis Therapeutics PLC - London-based biopharmaceutical company focused on addiction and mental health disorders - Raises £1.3 million through a direct subscription with certain institutional and existing strategic investors at £0.0033 per share. Proceeds will enable Solvonis to broaden its research and development activities. ‘This financing marks an important time for Solvonis as we evolve into a broader CNS biopharmaceutical company. Our focus now spans addiction, psychiatry, and neurology - three interlinked areas of enormous unmet need. The continued support of our core investors enables us to accelerate our discovery work and deepen our development programmes across these pillars, advancing our mission to deliver innovative therapies for high-burden CNS disorders,’ says Chief Executive Officer Anthony Tennyson. ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
